Mr David Gillespie
Projects as PI
- Antibiotic duration optimisation for UTI (Optimise UTI) (01/08/2022 - 31/07/2025)
- Behavioural activation (Beatit) for depression in adults with severe intellectual disabilities: A feasibility randomised controlled study of Beatit versus treatment as usual (01/09/2018 - 31/08/2020)
- Development of an intervention to optimise use of pre-exposure prophylaxis (PrEP) to prevent HIVacquisition in at-risk individuals living in Wales (DO-PrEP) (01/10/2018 - 31/03/2024)
- Mapping and evaluating services for children with learning disabilities and behaviours that challenge (MELD) (01/02/2021 - 30/04/2024)
- One year likelihood of relapse in ulcerative colitis (UC) is predicted by mucosal appearance but not by faecal calprotectin: Data from the coda study of once daily versus three times daily asacol (28/11/2012 - 27/02/2013)
Projects as Co-Investigator
- A Cluster Randomised Controlled Trial of Early Positive Approaches to
Support (E-PAtS) for families of young children with intellectual disability (01/04/2023 - 30/06/2026) - ANti-psychotic drug Reduction in primary care for adults with learning disabilities (ANDREA-LD): A randomised double-blind placebo controlled trial (01/10/2013 - 31/12/2017)
- A pragmatic randomised controlled trial of sensory integration therapy versus usual care for sensory processing difficulties in autism spectrum disorder in children: Impact on behavioural difficulties, adaptive skills and socialisation (SenlTA) (01/01/2017 - 30/06/2024)
- A randomised feasibility study of a school-based emotional literacy programme (Zippy's Friends) for children with intellectual disabilities (01/03/2020 - 31/01/2023)
- Bacterial mucosal immunotherapy for prevention of wheeze in preterm born infants (BALLOON Trial) (01/03/2024 - 31/03/2028)